Search results for "macula"

showing 10 items of 345 documents

Optical Coherence Tomography Characterization of Macular Changes Secondary to Arteriovenous Fistula

2017

Arteriovenous fistulas (AVFs) are abnormal shunts between the arterial and venous vascular systems. These usually produce ocular pain, increased intraocular pressure (IOP), and diplopia. Less frequently, they may cause retinal changes with visual impairment. Our purpose is to illustrate different retinal manifestations of AVF. We report the multimodal imaging study of three cases with retinal changes due to AVF, showing neurosensory retinal detachment, macular oedema, and macular ischemia. In conclusion, AVF may appear with different ophthalmic alterations. While usually increased IOP and diplopia are our main concerns, retinal study is mandatory, since a myriad of morphologic abnormalities…

medicine.medical_specialtyIntraocular pressurecongenital hereditary and neonatal diseases and abnormalitiesgenetic structuresArteriovenous fistulaCase Report03 medical and health scienceschemistry.chemical_compound0302 clinical medicineOptical coherence tomographyOphthalmologymedicinemaculacardiovascular diseasesCarotid-cavernous fistulaArteriovenous fistulaMultimodal imagingDiplopiaoptical coherence tomographymedicine.diagnostic_testbusiness.industryRetinal detachmentRetinalmedicine.diseaseeye diseasesSurgeryOphthalmologychemistryOCT030221 ophthalmology & optometryNeurology (clinical)sense organsmedicine.symptombusinesscarotid-cavernous fistula030217 neurology & neurosurgery
researchProduct

Fluocinolone acetonide vitreous insert for chronic diabetic macular oedema: a systematic review with meta-analysis of real-world experience

2021

AbstractWe conducted a meta-analysis of real-world studies on the 0.19 mg Fluocinolone Acetonide (FAc) intravitreal implant for chronic diabetic macular oedema (DMO), comparing these findings with the Fluocinolone Acetonide for Diabetic Macular Edema (FAME) study. The primary outcome was mean change of best corrected visual acuity (BCVA) at 24 months. Secondary outcomes were 36-month mean BCVA, mean central macular thickness (CMT) change, rates of eyes receiving supplementary intravitreal therapy, cataract surgery, intraocular pressure (IOP)-lowering drops and glaucoma surgery. Mean differences (MDs) with 95% confidence intervals (CIs) were calculated. Nine real-world studies were included.…

medicine.medical_specialtyIntraocular pressuregenetic structuresSciencemedicine.medical_treatmentAnti-Inflammatory AgentsArticleMacular Edema03 medical and health sciences0302 clinical medicineDiabetes complicationsFluocinolone acetonideOphthalmologymedicineGlaucoma surgeryHumans030212 general & internal medicineGlucocorticoidsIntraocular PressureDrug ImplantsDiabetic RetinopathyMultidisciplinarybusiness.industryQRCataract surgeryRetinal diseaseseye diseasesConfidence intervalFluocinolone AcetonideDiabetic macular oedemaMeta-analysis030221 ophthalmology & optometryMedicinesense organsImplantbusinessmedicine.drugScientific Reports
researchProduct

Do nutritional supplements have a role in age macular degeneration prevention?

2013

Purpose. To review the proposed pathogenic mechanisms of age macular degeneration (AMD), as well as the role of antioxidants (AOX) and omega-3 fatty acids (ω-3) supplements in AMD prevention.Materials and Methods. Current knowledge on the cellular/molecular mechanisms of AMD and the epidemiologic/experimental studies on the effects of AOX andω-3 were addressed all together with the scientific evidence and the personal opinion of professionals involved in the Retina Group of the OFTARED (Spain).Results. High dietary intakes ofω-3 and macular pigments lutein/zeaxanthin are associated with lower risk of prevalence and incidence in AMD. The Age-Related Eye Disease study (AREDS) showed a benefic…

medicine.medical_specialtyLuteineicosapentaenoic acidgenetic structuresmedicine.medical_treatmentSuplements nutritiusPhysiologypigment epithelial-celllsReview ArticleLower riskAntioxidantsclinical-trialchemistry.chemical_compoundlcsh:Ophthalmologybeta-CaroteneOPHTHALMOLOGYOmega-3 fatty acidsMedicineoxidative stressbusiness.industryVitamin Evitamin-EPreventionblue mountains eyeMacular degenerationMicronutrientmedicine.diseaseDietary supplementsEicosapentaenoic acidbeaver dam eyeAge macular degeneration (AMD)Retinal diseaseseye diseasesSurgeryZeaxanthinOphthalmologybeta-caroteneMalalties de la retinachemistrylcsh:RE1-994fatty-acid compositionsense organsbusinessgrowth-factor VEGFJournal of ophthalmology
researchProduct

Development of choroidal neovascularization following transpupillary thermotherapy (TTT) for a small malignant melanoma of the choroid at the posteri…

2010

Abstract Introduction The malignant melanoma of the choroid is the most common primary malignant intraocular tumor in adults. There are currently several methods available for the treatment of choroidal melanomas. Among others, hyperthermia represents a therapeutic approach in which infrared radiation is delivered through the dilated pupil, called “transpupillary thermotherapy (TTT)”. The method was initially assumed to cause only a few side effects but gradually more and more complications have been observed. The treatment is associated with a number of vascular responses, for example arterial and venous occlusions. However neovascularizations of the choroid have only been detected twice s…

medicine.medical_specialtyPathologygenetic structureseducationPosterior poleDermatologychemistry.chemical_compoundOphthalmologymedicineRetinal pigment epitheliummedicine.diagnostic_testbusiness.industryMelanomaMacular degenerationmedicine.diseaseeye diseasesmedicine.anatomical_structureChoroidal neovascularizationchemistryAngiographySurgerysense organsChoroidmedicine.symptombusinessIndocyanine greenMedical Laser Application
researchProduct

Recent advances and disputes about curcumin in retinal diseases

2021

Abstract Curcumin belongs to the group of so-called phytocompounds, biologically active molecules produced by plants exerting a beneficial effect on health. Curcumin shows a wide spectrum of different properties, being an anti-inflammatory, antioxidant, antimicrobial and antimutagenic molecule. The purpose of the review is to examine what literature reported on the characteristics of curcumin, particularly, on the beneficial and controversial aspects of this molecule, aiming for a better therapeutic management of retinal diseases. The retina is a constant target of oxidative stress, this tissue being characterized by cells rich in mitochondria and by vessels and being, obviously, continuous…

medicine.medical_specialtyProliferative vitreoretinopathyantioxidant proprietiesReviewexosomesPharmacologymedicine.disease_causeRetinal ganglionanti-inflammatory proprieties; antioxidant proprieties; exosomes; miRNA; nanosphere; natural compounds03 medical and health scienceschemistry.chemical_compound0302 clinical medicineOphthalmologymedicinenatural compoundsanti-inflammatory proprietiesmiRNARetinabusiness.industryRetinalDiabetic retinopathyMacular degenerationmedicine.diseasenanosphereOphthalmologymedicine.anatomical_structurechemistry030221 ophthalmology & optometryCurcuminbusiness030217 neurology & neurosurgeryOxidative stress
researchProduct

Atrophic Forms (Dry AMD)

2009

Atrophic form of “Dry AMD” is defined by areas of RPE atrophy, often resulting from regression of confluent soft drusen.

medicine.medical_specialtyRPE atrophymedicine.anatomical_structuregenetic structuresbusiness.industryOphthalmologyMacular atrophymedicinesense organsSoft drusenOuter nuclear layerbusinesseye diseases
researchProduct

Safety and Efficacy of Ranibizumab in Macular Edema following Retinal Vein Occlusion.

2013

Macular edema is the leading cause of visual impairment in patients with retinal vein occlusion. Limited improvements may be obtained with laser photocoagulation or intravitreal triamcinolone. However, according to the data provided by randomized clinical trials, intravitreal injections of ranibizumab (Lucentis; Genentech, South San Francisco, CA) constitute a new effective and safe option for the management of these vision-threatening diseases. The aim of the present review is to summarize the clinical evidence of ranibizumab for macular edema due to retinal vein occlusions.

medicine.medical_specialtyRetinal Veingenetic structuresReviewlaw.inventionRandomized controlled triallcsh:OphthalmologylawOphthalmologyOcclusionMedicineIn patientranibizumabMacular edemaIntravitreal triamcinolonemacular edemabusiness.industrymedicine.diseaseVEGFeye diseasesantiangiogenic therapylcsh:RE1-994retinal vein occlusionRetinal vein occlusionsRanibizumabbusinessBiomedical engineeringmedicine.drugOphthalmology and eye diseases
researchProduct

Serous Macular Detachment Associated with Dome-Shaped Macula and Tilted Disc

2011

Introduction: An entirely new type of staphyloma has been recently described as dome-shaped macula (DSM). It is characterized by an abnormal convex macular contour within the concavity of a posterior staphyloma. We found DSM associated with serous macular detachment (SMD) and tilted disc in two consecutive cases. Case Reports: Case 1: A 37-year-old female presented to our department because of sudden onset blurred vision in her right eye (OD). The best-corrected visual acuity (BCVA) was 0.5 in both eyes. Funduscopy evidenced bilateral tilted disc associated with posterior staphyloma. Optical coherence tomography (OCT) demonstrated a DSM with SMD in her OD. After 15 months of follow-up, BCVA…

medicine.medical_specialtySerous macular detachmentVisual acuitygenetic structuresDome-shaped maculaOpticslcsh:OphthalmologyOptical coherence tomographyBlurred visionOphthalmologymedicineTilted discmedicine.diagnostic_testbusiness.industrySerous macular detachmentStaphylomaPublished: March 2011Posterior staphylomamedicine.diseaseeye diseasesOphthalmologyLeft eyelcsh:RE1-994Posterior staphylomasense organsmedicine.symptombusinessSudden onsetCase Reports in Ophthalmology
researchProduct

Intravitreal dexamethasone implant for cystoid macular edema and inflammation after scleral buckling

2015

Purpose Cystoid macular edema may occur following scleral buckling and therefore deteriorate the visual outcome. Inflammation may be the major causative factor in the development of postoperative cystoid macular edema. This case demonstrates the effectiveness of a dexamethasone implant as a treatment after the onset of choroidal inflammation and cystoid macular edema 6 months following scleral buckling and having visual acuity restored. Methods A 59-year-old phakic woman treated with scleral buckling for macula-off retinal detachment presented 2 months after surgery with cystoid macular edema with choroidal inflammation. Optical coherence tomography and fluorescein angiography were performe…

medicine.medical_specialtyTriamcinolone acetonideVisual acuityChoroiditisgenetic structuresVisual AcuityTriamcinolone AcetonideDrug ImplantDexamethasoneMacular EdemaChoroiditiPostoperative ComplicationsGlucocorticoidOptical coherence tomographyOphthalmologyChoroidal inflammationMedicineHumansFluorescein AngiographyMacular edemaGlucocorticoidsDexamethasoneDrug Implantsmedicine.diagnostic_testbusiness.industryIntravitreal InjectionRetinal DetachmentRetinal detachmentGeneral MedicineIntravitreal dexamethasone implantMiddle Agedmedicine.diseaseFluorescein angiographyeye diseasesOphthalmologyScleral BucklingIntravitreal InjectionsFemalesense organsImplantPostoperative Complicationmedicine.symptombusinessCystoid macular edemaTomography Optical Coherencemedicine.drugHuman
researchProduct

Visual processing in patients with age-related macular degeneration performing a face detection test

2017

Purpose: People with age-related macular degeneration (AMD) have difficulties in familiar face recognition and facial expression discrimination. Our aim was to evaluate the visual processing of faces in AMD patients and whether this would be improved by anti-vascular endothelial growth factor therapy. This was a prospective interventional cohort study. Patients: Twelve patients with monocular wet AMD and 6 control subjects were recruited. Face detection processes were studied using cortical event-related potentials (ERPs). Patients received 3 bevacizumab intravitreal injections to the single affected eye. At baseline and 4–6 weeks after the last injection, clinical presentation and ERPs of …

medicine.medical_specialtyVisual acuityBevacizumabgenetic structuresfacial expressionsElectroencephalographybevacizumabfacial recognitionVisual processing03 medical and health sciences0302 clinical medicineOphthalmologymedicineilmeetEEGage-related eye diseasesFace detectionta315tunnistaminenOriginal ResearchFacial expressionMonocularmedicine.diagnostic_testbusiness.industryvisuaalisuuseye diseasesta3141Clinical OphthalmologyMacular degenerationRE1-994medicine.diseaseeye diseasesOphthalmologyvisualityN170silmätaudit030221 ophthalmology & optometrysense organsmedicine.symptomrecognitionbusiness030217 neurology & neurosurgerykasvontunnistus (tietotekniikka)medicine.drugface recognitionClinical Ophthalmology
researchProduct